Japanese Capital Markets Stock News

Internet Initiative Japan (TSE:3774) just announced it will become an authorized reseller of Starlink services in Japan, starting December 2025. The company will focus on corporate clients and supporting disaster response efforts. See our latest analysis for Internet Initiative Japan. IIJ’s Starlink partnership comes as the stock regains momentum, with a 1-month share price return of 9.4%, reversing earlier softness this year. Despite a modest 1-year total shareholder return of -1.2%, the...

Yutaka Foods (TSE:2806) posted a notable turnaround in its latest results, with net profit margins climbing to 4.3% from 3.6% last year and annual earnings growing 21.2% compared to a five-year average annual decline of 18.3%. While recent numbers highlight a meaningful rebound and improved profitability, the company's longer-term track record still reflects sustained earnings pressure. Investors will be weighing these profit gains against a premium valuation, as the stock trades at 29.8x...

Inaba Denki Sangyo Ltd. (TSE:9934) posted net profit margins of 5.3%, up from 4.5% last year, with earnings climbing 26.5% this period. Looking back, the company has averaged 12.2% annual earnings growth over the last five years, and ongoing profit momentum has outpaced historical trends. Investors will note that profit and revenue growth remain strong drivers this season, though the mixed valuation and a flagged risk on dividend sustainability add nuance to the overall picture. See our full...

SCREEN Holdings (TSE:7735) delivered a net profit margin of 14.9%, matching last year’s figure, while earnings are projected to rise 7.4% per year. Revenue is forecast to grow at 5.1% annually, just ahead of the 4.5% pace set by the broader Japanese market. However, earnings growth is expected to lag slightly behind the national rate of 7.8%. Investors will note the company has enjoyed remarkable annual earnings growth of 32.7% over the past five years, slowing to 11.3% in the most recent...

Otsuka (TSE:4768) reported earnings growth of 24.4% over the past year, outpacing its five-year average of 9.1% per year. Future expectations show earnings are forecast to grow 3.88% annually, while revenue is seen rising 1.9% per year; both rates trail the broader Japanese market. Net profit margins ticked up to 4.9% from last year’s 4.8%, and the current Price-To-Earnings ratio of 18.2x is below its peer average but above the industry mean, with shares trading at ¥3,050. See our full...

Sumitomo Pharma (TSE:4506) has returned to profitability over the past year, with a marked improvement in net profit margins following a stretch of negative earnings. Revenue is forecast to grow at 5.3% per year, outpacing the Japanese pharmaceuticals market’s 4.5% average. However, EPS is expected to trend lower at an average rate of -21.2% per year over the next three years. This turn to positive margins and a low Price-To-Earnings Ratio of 4.3x compared to industry and peer averages...

Daiichi Sankyo (TSE:4568) posted a 32.7% annual earnings growth over the last five years, with the most recent period showing an 11.8% rise in earnings. Looking ahead, earnings are forecast to grow by 14.05% per year alongside an expected 9.6% increase in revenue. This would notably outpace the broader Japanese market’s 4.5% annual revenue growth rate. With current net profit margins at 14.1% and a price-to-earnings ratio of 24.3x, investors find themselves weighing healthy profit growth...

JTEKT Corporation recently reported a very large 95.2% year-on-year increase in profit attributable to owners for the half-year ended September 30, 2025, and revised its full-year guidance to reflect changes in revenue expectations and profitability. This update highlights the company’s ability to adjust its financial outlook amid market opportunities and shifting foreign exchange rates. We'll assess how JTEKT’s significant profit surge and updated guidance influence its investment narrative...

Fukuda Denshi (TSE:6960) reported net earnings growth of 11.4% over the last year, beating its 5-year average growth rate of 6.8% per year, while net profit margin climbed to 13.2% from 12% a year ago. Looking ahead, earnings are forecast to increase at 4.33% per year, with revenue expected to grow 2.3% per year, both of which lag behind the broader Japanese market averages. With a price-to-earnings ratio of 10.3x, well below industry and peer benchmarks, and profit metrics trending...

TOTO (TSE:5332) posted a one-off loss of ¥38.8 billion for the twelve months ending September 30, 2025, driving its net profit margin down to 0.6% from last year’s 5.2%. Over the last five years, the company’s earnings have declined by an average of 5.5% per year. Looking ahead, forecasts point to revenue growth of 2.6% each year, which trails the broader Japanese market, while consensus estimates signal robust annual earnings growth of 30.9%. With a recent dip in margins and questions about...

Sumitomo (TSE:8053) reported net profit margins of 8.3%, up from 5% a year earlier, with EPS rising sharply as earnings surged 71.4% year-over-year, which is more than double the company’s five-year average annual earnings growth of 30.1%. While the company’s profitability and high-quality earnings have drawn attention, management is signaling caution, as revenue is forecast to rise 4.5% annually in line with the broader Japanese market but earnings are expected to edge down slightly at...

F&MLtd (TSE:4771) delivered a net profit margin of 10.9% this year, up from 9% last year, with annual earnings surging 49.2%. This growth rate is well ahead of its five-year compound annual rate of 13.3%. Over the past five years, earnings have grown at 13.3% per year, with the latest results highlighting a track record of high-quality profitability. See our full analysis for F&MLtd. Next, we will measure these headline numbers against the prevailing narratives for F&MLtd. Some expectations...

Last week, you might have seen that Disco Corporation ( TSE:6146 ) released its interim result to the market. The early...

Daito Pharmaceutical Co.,Ltd.'s ( TSE:4577 ) investors are due to receive a payment of ¥20.00 per share on 3rd of...

Kamakura Shinsho, Ltd. ( TSE:6184 ) has announced that it will pay a dividend of ¥20.00 per share on the 21st of April...

Feed One Ltd. (TSE:2060) posted steady earnings growth at an annual rate of 8.5% over the past five years; however, the latest filing reveals recent momentum has slowed, with earnings growth declining over the past year and net profit margin contracting to 1.8% from 2% a year ago. Against this softer near-term result, the market sees a valuation opportunity: shares trade at just 7.5 times earnings, well below the Japanese food industry average of 16.3 times and a peer group average of 25.7...

LIXIL (TSE:5938) has swung to profitability over the past year, now forecasting earnings growth of 30.7% per year, significantly outpacing the Japanese market's 7.8% annual forecast. Revenue growth, however, is expected to lag at just 2.5% per year compared to the market average of 4.5%. With earnings having declined by 37.6% annually over the past five years, these new growth projections mark a major shift for the business. This sets the stage for a sharply improved net profit margin and...

Last week saw the newest half-yearly earnings release from SAKURA Internet Inc. ( TSE:3778 ), an important milestone in...

Ryoyu Systems Co., Ltd. ( TSE:4685 ) shares have had a really impressive month, gaining 25% after a shaky period...

It's been a mediocre week for Japan Aviation Electronics Industry, Limited ( TSE:6807 ) shareholders, with the stock...

Yamato Holdings Co., Ltd. ( TSE:9064 ) shareholders are probably feeling a little disappointed, since its shares fell...

Mitsubishi Chemical Group (TSE:4188) reported a revenue growth forecast of just 0.04% per year, far lower than the broader Japanese market’s 4.5% expectation. Net profit margin has narrowed to 0.9% from last year’s 2.1%, yet over the past five years, the company has managed to return to profitability and has grown earnings at a healthy 10.7% annually. Looking ahead, earnings are projected to jump 21.9% per year, nearly triple the Japanese market average of 7.8%, with shares trading at ¥806.1,...

As you might know, Takeda Pharmaceutical Company Limited ( TSE:4502 ) last week released its latest interim, and things...

Fuji Nihon (TSE:2114) reported EPS growth of 6.7% over the past year, a pace slower than its five-year annual average of 19%. The company maintained a net profit margin of 9.5%, matching last year's level, with high-quality earnings reported once again. While earnings growth moderated this time around, investors will note that Fuji Nihon's shares trade at ¥1,051, which is well below an estimated fair value, supported by strong historical earnings consistency and attractive valuation metrics...